Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00010712 · ClinicalTrials.gov registry record · Phase 2
Effects of Black Cohosh on Menopausal Hot Flashes
A Phase 2 study of Hot Flashes and Osteoporosis, Postmenopausal, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 1
- Study location
NCT00010712 is a Phase 2 study of Hot Flashes and Osteoporosis, Postmenopausal that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The trial reports 1 study location across 1 state.
The verdict
NCT00010712, a Phase 2 study of Hot Flashes and Osteoporosis, Postmenopausal, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1
- Study location
Study Summary
This study will assess whether treatment with black cohosh is effective in reducing the frequency and intensity of menopausal hot flashes. In addition, this study will determine whether or not black cohosh reduces the frequency of other menopausal symptoms and improves quality of life.
Conditions Studied
Interventions
- DRUG Black Cohosh
Study Locations (1)
New York
- Columbia University Rosenthal Center for CAM - New York
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-09 |
| Est. Completion | 2005-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00010712
The ClinicalTrials.gov registry entry for NCT00010712 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Hot Flashes appearing as the primary indexed condition, and to 1 intervention - of which Black Cohosh is the first listed.
NCT00010712 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00010712 about?
NCT00010712 is a clinical study titled "Effects of Black Cohosh on Menopausal Hot Flashes". This study will assess whether treatment with black cohosh is effective in reducing the frequency and intensity of menopausal hot flashes. In addition, this study will determine whether or not black cohosh reduces the frequency of other menopausal symptoms and improves quality of life.
What is the current status of trial NCT00010712?
This trial is currently completed. It is a Phase 2 study. The study started on 1999-09. Estimated completion is 2005-07.
What conditions does trial NCT00010712 study?
This clinical trial studies the following conditions: Hot Flashes, Osteoporosis, Postmenopausal, Postmenopause.
What interventions are being tested in trial NCT00010712?
The interventions under investigation include: Black Cohosh (DRUG).
Who is sponsoring clinical trial NCT00010712?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00010712 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hot Flashes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
RECRUITING · Phase 2
-
Eight-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Associated With Menopause
COMPLETED · Phase 2
-
Use of Black Cohosh and Red Clover for the Relief of Menopausal Symptoms
COMPLETED · Phase 2
-
Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease
COMPLETED · Phase 2
-
Research Investigation of Soy and Estrogen
COMPLETED · Phase 2
-
Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.